Holmes George B, Lin Johnny
Department of Orthopaedic Surgery, Rush University Medical School, 800 South Wells, M30, Chicago, IL 60607, USA.
Foot Ankle Int. 2006 Nov;27(11):952-9. doi: 10.1177/107110070602701115.
The purpose of this study was to determine if a statistical association exists between Achilles tendinopathy (also referred to as tendinosis) and obesity, diabetes mellitus, hypertension, the supplemental use of estrogen, and exposure to local or systemic steroids.
From July, 1997, to February, 2003, 82 patients with a diagnosis of Achilles tendinopathy were identified. The diagnosis of Achilles tendinopathy was confirmed by a review of medical records, radiographs, and MRI. There were 44 women and 38 men with an average age of 50 (range 27 to 77) years. For the parameters of obesity, hypertension, diabetes, steroid exposure, and the use of estrogen compounds, all patients were analyzed both cumulatively and stratified into subgroups by gender and age. Chi-square 2 x 2 tables were used to compare the observed prevalence of the parameters in patients with Achilles tendinopathy to the expected prevalence of these disorders and exposures in the population at large.
Cumulatively, 98% percent (43 of 44 women; 29 of 38 men) had hypertension, diabetes, obesity, and steroid or estrogen exposure. Seventy-six percent of men (29) had hypertension, diabetes, and obesity, or steroid exposure. Sixty-eight percent of women (15 of 22) had a history of hormone replacement therapy and 44% (8 of 15) had a positive history for use of oral contraceptives. When compared with published national data using Chi-square analysis, the association between tendinopathy and hormone replacement therapy and oral contraceptives was found to be statistically significant with p-values of 0.01 and 0.001, respectively. For both women and men, obesity was statistically associated with Achilles tendinopathy with p-values of 0.025 and. 001, respectively. Hypertension was statistically associated with Achilles tendinopathy only for women. Diabetes mellitus and Achilles tendinopathy were found to have a statistical association only for men younger than 44 years old
Obesity, hypertension, and steroids have as their end-organ effect a diminution of local microvascularity. The significant correlation of these factors with Achilles tendinopathy suggests the importance of their effect on microvascularity in the development of Achilles tendinopathy.
本研究的目的是确定跟腱病(也称为肌腱病)与肥胖、糖尿病、高血压、雌激素补充使用以及局部或全身类固醇暴露之间是否存在统计学关联。
从1997年7月至2003年2月,共确定了82例诊断为跟腱病的患者。通过查阅病历、X光片和核磁共振成像(MRI)确诊跟腱病。其中有44名女性和38名男性,平均年龄为50岁(范围27至77岁)。对于肥胖、高血压、糖尿病、类固醇暴露以及雌激素化合物使用等参数,对所有患者进行了累积分析,并按性别和年龄分层为亚组。使用卡方2×2表格将跟腱病患者中各参数的观察患病率与这些疾病和暴露在总体人群中的预期患病率进行比较。
累积来看,98%(44名女性中的43名;38名男性中的29名)患有高血压、糖尿病、肥胖症以及类固醇或雌激素暴露。76%的男性(29名)患有高血压、糖尿病和肥胖症,或有类固醇暴露。68%的女性(22名中的15名)有激素替代疗法史,44%(15名中的8名)有口服避孕药使用史。与已发表的全国数据进行卡方分析比较时,发现肌腱病与激素替代疗法和口服避孕药之间的关联具有统计学意义,p值分别为0.01和0.001。对于女性和男性,肥胖与跟腱病在统计学上均相关,p值分别为0.025和0.001。高血压仅在女性中与跟腱病在统计学上相关。糖尿病与跟腱病仅在44岁以下男性中存在统计学关联。
肥胖、高血压和类固醇的终末器官效应是局部微血管减少。这些因素与跟腱病的显著相关性表明它们对微血管的影响在跟腱病发展中的重要性。